Usefulness of Fine-Needle Aspiration Biopsy before Performing Ultrasound-Guided Vacuum-Assisted Excision
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Ultrasound-guided vacuum-assisted excision (US-VAE) is considered the less invasive method for the histological assessment of breast lesions than surgical excision and also used for removing benign lesions. Some benign lesions require further excision after removing them by US-VAE, because pathologic diagnosis with specimen obtained by US-VAE cannot be confirmative. However, a well-targeted fine-needle aspiration biopsy (FNAB) before US-VAE can provide preoperative diagnosis. The aim of this study is to evaluate the accuracy and safety of FNAB to minimize further excision after performing US-VAE. Methods: From June 2007 to December 2009, US-VAE was performed on 321 patients with benign breast lesions which diagnosed by FNAB. Clinicopathological data, medical records and imaging studies were reviewed. We estimated the further excision rate after carrying out US-VAE and evaluated effectiveness of FNAB for pathologic diagnosis of breast lesions before performing US-VAE. Results: Of 321 lesions, 118 (27.1%) were diagnosed as specific benign, 201 patients (57.9%) as other nonspecific benign or negative malignant cell, 2 (0.6%) as atypical ductal hyperplasia (ADH) at FNAB. The pathologic diagnoses after US-VAE were usually specific benign diseases; fibroadenoma (190 cases, 59.2%), fibrocystic change (51 cases, 15.9%), other benign (68 cases, 21.2%). As indeterminate lesions, ADH (5 cases, 1.6%), borderline phyllodes tumor (4 cases, 1.2%) were diagnosed. Of 321, only three patients (0.9%) were underwent further excision for malignancy. They were diagnosed as malignant after taking US-VAE, two lobular carcinoma in situ and one invasive ductal carcinoma. Conclusion: US-VAE is relatively accurate and effective for removing benign lesion of breast. To reduce the further excision rate, the cytological and pathological confirmation using FNAB should be performed precisely before performing the US-VAE.
Abstract
Purpose: Ultrasound-guided vacuum-assisted excision (US-VAE) is considered the less invasive method for the histological assessment of breast lesions than surgical excision and also used for removing benign lesions. Some benign lesions require further excision after removing them by US-VAE, because pathologic diagnosis with specimen obtained by US-VAE cannot be confirmative. However, a well-targeted fine-needle aspiration biopsy (FNAB) before US-VAE can provide preoperative diagnosis. The aim of this study is to evaluate the accuracy and safety of FNAB to minimize further excision after performing US-VAE. Methods: From June 2007 to December 2009, US-VAE was performed on 321 patients with benign breast lesions which diagnosed by FNAB. Clinicopathological data, medical records and imaging studies were reviewed. We estimated the further excision rate after carrying out US-VAE and evaluated effectiveness of FNAB for pathologic diagnosis of breast lesions before performing US-VAE. Results: Of 321 lesions, 118 (27.1%) were diagnosed as specific benign, 201 patients (57.9%) as other nonspecific benign or negative malignant cell, 2 (0.6%) as atypical ductal hyperplasia (ADH) at FNAB. The pathologic diagnoses after US-VAE were usually specific benign diseases; fibroadenoma (190 cases, 59.2%), fibrocystic change (51 cases, 15.9%), other benign (68 cases, 21.2%). As indeterminate lesions, ADH (5 cases, 1.6%), borderline phyllodes tumor (4 cases, 1.2%) were diagnosed. Of 321, only three patients (0.9%) were underwent further excision for malignancy. They were diagnosed as malignant after taking US-VAE, two lobular carcinoma in situ and one invasive ductal carcinoma. Conclusion: US-VAE is relatively accurate and effective for removing benign lesion of breast. To reduce the further excision rate, the cytological and pathological confirmation using FNAB should be performed precisely before performing the US-VAE.
참고문헌 (27)
- Cassano E, "Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases", Breast Cancer Res Treat, 102, pp.103~110 (2007)
- Fine RE, "Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance", Am J Surg, 184, pp.332~336 (2002)
- Smith DN, "The utility of ultrasonographically guided large-core needle biopsy: results from 500 consecutive breast biopsies", J Ultrasound Med, 20, pp.43~49 (2001)
- Nakano S, "Evaluation and indications of ultrasound-guided vacuum-assisted core needle breast biopsy", Breast Cancer, 14, pp.292~296 (2007)
- Heywang-Köbrunner SH, "Use of ultrasound-guided percutaneous vacuum-assisted breast biopsy for selected difficult indications", Breast J, 15, pp.348~356 (2009)
- Bruening W, "Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions", Ann Intern Med, 152, pp.238~246 (2010)
- American College of Radiology, "Breast Imaging Reporting and Data System Breast Imaging Atlas" (2003), American College of Radiology
- Ko EY, "Factors affecting the efficacy of ultrasound-guided vacuum-assisted percutaneous excision for removal of benign breast lesions", J Ultrasound Med, 27, pp.65~73 (2008)
- Schueller G, "Accuracy of ultrasound-guided, large-core needle breast biopsy", Eur Radiol, 18, pp.1761~1773 (2008)
- Usami S, "Pathological aspects of core needle biopsy for non-palpable breast lesions", Breast Cancer, 12, pp.272~278 (2005)
- Nguyen M, "An update on core needle biopsy for radiologically detected breast lesions", Cancer, 78, pp.2340~2345 (1996)
- Fajardo LL, "Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study", Acad Radiol, 11, pp.293~308 (2004)
- Brenner RJ, "Operative Techniques in General Surgery", pp.104~109 (2000), W. B. Saunders Company
- Verkooijen HM, "Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation", Int J Cancer, 99, pp.853~859 (2002)
- Kuo YL, "Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions?", BMC Cancer, 10, pp.371~ (2010)
- Britton PD, "Fine needle aspiration or core biopsy", Breast, 8, pp.1~4 (1999)
- Leifland K, "Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 non-palpable breast lesions", Acta Radiol, 44, pp.387~391 (2003)
- Ishikawa T, "False-positive and false-negative cases of fine-needle aspiration cytology for palpable breast lesions", Breast Cancer, 14, pp.388~392 (2007)
- Yeoh GP, "Fine needle aspiration of breast masses: an analysis of 1533 cases in private practice", Hong Kong Med J, 4, pp.283~288 (1998)
- Boerner S, "Ultrasound-guided fine-needle aspiration (FNA) of nonpalpable breast lesions: a review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA", Cancer, 87, pp.19~24 (1999)
- Ciatto S, "Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies", Breast Cancer Res Treat, 101, pp.291~297 (2007)
- Helbich TH, "Coaxial technique: approach to breast core biopsies", Radiology, 203, pp.684~690 (1997)
- Parker SH, "Percutaneous large-core breast biopsy: a multi-institutional study", Radiology, 193, pp.359~364 (1994)
- Morris EA, "Histologic heterogeneity of masses at percutaneous breast biopsy", Breast J, 8, pp.187~191 (2002)
- Joshi M, "Atypical ductal hyperplasia in stereotactic breast biopsies: enhanced accuracy of diagnosis with the mammotome", Breast J, 7, pp.207~213 (2001)
- Adrales G, "Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by Mammotome?", Am J Surg, 180, pp.313~315 (2000)
- Grady I, "Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia", J Am Coll Surg, 201, pp.14~17 (2005)
